Dan Kaufman

Institution Name:

University of California, San Diego

Total Awards:

4

Award Value:

$6,675,468

Share

Awards as PI

Program Type	Institution	Grant Title	Award Value
Quest - Discovery Stage Research Projects	University of California, San Diego	Targeted off-the-shelf immunotherapy to treat refractory cancers	$1,936,936
Therapeutic Translational Research Projects	University of California, San Diego	Human Embryonic Stem Cell-Derived Natural Killer Cells for Cancer Treatment	$3,260,000
Quest - Discovery Stage Research Projects	University of California, San Diego	Human iPSC-derived chimeric antigen receptor-expressing macrophages for cancer treatment	$222,200
Quest - Discovery Stage Research Projects	University of California, San Diego	Human iPSC-derived chimeric antigen receptor expressing macrophages for improved cancer treatment.	$1,256,332
			Total: $6,675,468.00

Publications

Exp Hematol 2019 Development of innate immune cells from human pluripotent stem cells. (PubMed: 30611869)
Semin Immunopathol 2019 Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells. (PubMed: 30361801)
Cell Stem Cell 2018 Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity. (PubMed: 30082067)
Stem Cells 2018 Concise Review: Human Pluripotent Stem Cells to Produce Cell-Based Cancer Immunotherapy. (PubMed: 29235195)
Stem Cells 2021 Human induced pluripotent stem cell-derived macrophages ameliorate liver fibrosis. (PubMed: 34460131)